Total and regional bone mass and biochemical markers of bone remodeling in metastatic prostate cancer

Prostate

Volumn 35, Issue 4, 1998, Pages 243-247

  Revilla, M ^a   Arribas, I ^b   Sanchez Chapado, M ^b   Villa, L F ^a   Bethencourt, F ^b   Rico, H ^a  

^a UNIVERSITY OF ALCALÁ   (Spain)

^b HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

Author keywords

Bone mass; Bone metastases; Bone resorption; Dual energy X ray absorptiometry; Prostate cancer

Indexed keywords

ACID PHOSPHATASE; BIOCHEMICAL MARKER;

AGED; ARTICLE; BONE MASS; BONE METASTASIS; BONE MINERAL; BONE REMODELING; CLINICAL ARTICLE; DUAL ENERGY X RAY ABSORPTIOMETRY; HUMAN; MALE; OSTEOLYSIS; PRIORITY JOURNAL; PROSTATE CANCER;

ACID PHOSPHATASE; AGED; ALKALINE PHOSPHATASE; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; BONE DENSITY; BONE NEOPLASMS; BONE REMODELING; BONE RESORPTION; CALCIUM; DENSITOMETRY, X-RAY; HUMANS; ISOENZYMES; MALE; NEOPLASM METASTASIS; PROSTATIC NEOPLASMS; REFERENCE VALUES; REGRESSION ANALYSIS;

EID: 0032102963     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19980601)35:4<243::AID-PROS2>3.0.CO;2-H     Document Type: Article

References (31)

1. Rico H, Sanchez-Chapado M, Revilla M, Bethencourt F, Villa LF, Guil M: Total and regional bone mass in metastatic cancer of the prostate. Eur Urol 1996;30:73-76.
2. Minkin C: Bone acid phosphatase: Tartrate-resistant acid phosphatase as a marker of osteoclastic function. Calcif Tissue Int 1982;34:285-290.
3. Delmas PD: Biochemical markers of bone turnover for the clinical assessment of metabolic bone disease. Endocrinol Metab Clin North Am 1990;19:1-18.
4. Lieberherr M, Vreven J, Vraes G: The acid and alkaline phosphatases, inorganic pyrophosphatases and phosphoprotein phosphatase of bone. I. Characterization and assay. Biochim Biophys Acta 1971;293:160-169.
5. Susi FR, Goldhaber P, Jennings JM: Histochemical and biochemical study of acid phosphatase in resorbing bone in culture. Am J Physiol 1966;211:959-962.
6. Vaes G: On the mechanisms of bone resorption: The action of parathyroid hormone on the excretion and synthesis of lysosomal enzymes and on the extracellular release of acid by bone cells. J Cell Biol 1968;39:676-697.
7. Rico H, Villa LF: Serum tartrate-resistant acid phosphatase as a biochemical marker of bone remodeling. Calcif Tissue Int 1993; 52:149-150.
8. Lam KW, Yam YT: Biochemical characterization of the tartrate-resistant acid phosphatase of human spleen with leukemic reticuloendotheliosis as a pyrophosphatase. Clin Chem 1977;23: 89-94.
9. Janckila AJ, Woodford TA, Lam KW, Li CV, Tam LT: Protein-tyrosine phosphatase activity of hairy cell tartrate-resistant acid phosphatase. Leukemia 1992;6:199-203.
10. Catovsky D: Chronic lymphoid leukemias. In Hoffbrand AV, Lewis SM (eds): "Postgraduate Haematology," 3rd ed. Oxford: Heinemann Medical Books, 1989:418-450.
11. Percival RC, Urwin GH, Harris S, Yates AJ, Willians JL, Beneton M, Kanis JA: Biochemical and histological evidence that carcinoma of the prostate is associated with increased bone resorption. Eur J Surg Oncol 1987;13:41-49.
12. Hopkins SC, Nissenkorn J, Palmieri GMA, Ikard M, Moinuddin M, Soloway MS: Serial spot hydroxyproline/creatinine ratios in metastatic prostatic cancer. J Urol 1983;120:319-323.
13. Kylmälä T, Tammela T, Risteli L, Risteli J, Taube T, Elomaa I: Evaluation of the effect of oral clodronate on skeletal metastases with type 1 collagen metabolites. A controlled trial of the Finnish Prostate Cancer Group. Eur J Cancer 1993;29:821-825.
14. Rodan GA, Fleisch HA: Biphosphonates: Mechanisms of action. J Clin Invest 1996;97:2692-2696.
15. Rico H, Revilla M, Villa LF, Hernández ER, Fernández JP: Crush fracture syndrome in senile osteoporosis - A nutritional consequence? J Bone Miner Res 1992;7:317-319.
16. Parfitt AM: Chlorothiazide induced hypercalcemia in juvenile osteoporosis and hyperparathyroidism. N Engl J Med 1969;281: 55-59.
17. Descos L, Andre C, Beorghia S, Vincent C, Revillard JP: Serum levels of b2-microglobulin - A new marker of activity in Crohn's disease. N Engl J Med 1979;301:440-441.
18. Mundy GR, Martin TJ: Pathophysiology of skeletal complications of cancer. In Mundy GR, Martin TJ (eds): "Physiology and Pharmacology of Bone," Berlin: Springer-Verlag, 1993:641-671.
19. Hernández ER, Revilla M, Rico H: Total body bone mineral and pelvis bone mineral content as parameters of bone mass in men - A dual-energy X-ray absorptiometry study. Acta Anat (Basel) 1991;142:227-230.
20. Rico H, Revilla M, Villa LF, Alvarez de Buergo M, Ruiz-Contreras D: Determinants of total and regional bone mineral content and density in postpubertal normal women. Metabolism 1994;43:263-266.
21. Rico H, Revilla M, Cardenas JL, Villa LF, Fraile E, Martin FJ, Arribas I: Influence of weight and seasonal changes on radiogrammetry and bone densitometry. Calcif Tissue Int 1994;54: 385-388.
22. Eriksen EF, Brixen K, Charles P: New markers of bone metabolism: Clinical use in metabolic bone disease. Eur J Endocrinol 1995;132:251-263.
23. Rico H, Arnanz F, Revilla M, Perera S, Iritia M, Villa LF, Arribas I: Total and regional bone mineral content in women treated with GnRH agonists. Calcif Tissue Int 1993;52:354-357.
24. Revilla M, Iritia M, Arribas I, Alvarez de los Heros JI, Rico H: Tartrate-resistant acid phosphatase as a biological marker of bone remodeling and turnover in women in relation to their gonadal state. J Obstet Gynaecol 1992;12:191-194.
25. Scarnecchia L, Minisola S, Pacitti MT, Carnevale V, Romagnoli E, Rosso R, Mazzuoli GF: Clinical usefulness of serum tartrate-resistant acid phosphatase activity determination to evaluate bone turnover. Scand J Clin Lab Invest 1991;51:517-524.
26. Rico H, Revilla M, Arnanz F, Villa LF, Perera S, Arribas I: Total and regional bone mass values and biochemical markers of bone remodeling in endometriosis. Obstet Gynecol 1993;81:272-275.
27. Pérez-Jaraiz MD, Revilla M, Alvarez de los Heros JI, Villa LF, Rico H: Prophylaxis of osteoporosis with calcium, estrogens and/or eelcatonin: Comparative longitudinal study of bone mass. Maturitas 1996;23:327-332.
28. Kraenzlin ME, Lau KHW, Liang L, Freeman TK, Singer FR, Stepan J, Baylink DJ: Development of an immunoassay for human serum osteoclastic tartrate-resistant acid phosphatase. J Clin Endocrinol Metab 1990;71:442-451.
29. Tothill P, Avenell A, Reid DM: Precision and accuracy of measurements of whole-body bone mineral: Comparisons between Hologic, Lunar and Norland dual-energy X-ray absorptiometers. Br J Radiol 1994;67:1210-1217.
30. Heaney RP, Matkovic V: Inadequate peak bone mass. In Riggs BL, Melton IJ (eds): "Osteoporosis: Etiology, Diagnosis and Management," 2nd ed. Philadelphia: Lippincott-Raven, 1995: 115-131.
31. Miyamoto KK, McSherry SA, Robins SP, Besterman JM, Mohler JL: Collagen cross-link metabolites in urine as markers of bone metastases in prostatic carcinoma. J Urol 1994;151:909-913.